Home / About Us / News and Resources / Insights Newsletter

Bundled Solutions

We have a bundled solution for your organization

Insights Enterprise Newsletter

Insights Enterprise Newsletter
Insights Newsletter: Calm the hype about new cannabinoids, get the latest on natural insect and tick repellents, new CE for April, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: Clarify New Guidelines for Prevnar 20 and Vaxneuvance, Cannabinoids Getting COVID-19 Attention, and New CE for March, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: Clarify the Role of Paxlovid or Molnupiravir for COVID-19, COVID-19: Sniffing Out Treatments for Loss of Smell, and New CE for February, and More!

Clinical pharmacy leadership updates including information on the role of Paxlovid or Molnupiravir for COVID-19, treatments for loss of smell, and new CE for February, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: Clarify the Role of Turmeric for COVID-19 and Other Uses, Kicking Bad Habits: Do Any Natural Medicines Help?, and New CE for January, and More!

Clinical pharmacy leadership updates including information on turmeric for COVID-19, latest updates on Kicking Bad Habits: Do Any Natural Medicines Help, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: Stay Alert for Errors with COVID-19 Vaccines, What is Psilocybin?, New CE for December, and More!

Clinical pharmacy leadership updates including information on vaccine error prevention, latest updates on psilocybin, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: When to Give COVID-19 Boosters, What is Delta-8 THC, New CE for November, and More!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: Flu Vaccines in 2021-2022, Acquisition of Bula Intelligence, New CE for October, and More!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights Newsletter: First Med for COVID-19 Post-Exposure Prophylaxis, New CE for September, and More!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights for: Why Aduhelm Isn’t a Miracle for Alzheimer’s, Latest COVID-19 Resources, New CE for August, and more!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More
Insights Enterprise Newsletter
Insights for: Watch for Unexpected Ingredients in New Zantac Products, Latest COVID-19 Resources, New CE for July, and more!

Clinical pharmacy leadership updates including improving access to buprenorphine for opioid use disorder, new training products, and more.

Read More